"HDAC11 was initially identified as a negative regulator of the well-known anti-inflammatory cytokine IL-10. Hence antagonizing HDAC11 activity may have anti-tumor potential whereas activating HDAC11 may be useful to treat chronic inflammation or autoimmunity."xsd:string